FINWIRES · TerminalLIVE
FINWIRES

ServiceNow's Strong AI Growth in Q1 Offset by Margin Pressure, Softer Outlook, Oppenheimer Says

By

ServiceNow (NOW) posted strong Q1 results driven by robust AI business growth, but softer organic revenue trends and a slightly weaker margin outlook weighed on the overall forecast, Oppenheimer said in a Thursday note.

Oppenheimer noted that AI-related demand remains a key strength and could account for more than 10% of total revenue this year, potentially easing concerns about AI disruption and supporting a higher valuation multiple over time.

The analyst flagged softer Q2 guidance, slower organic growth, and margin pressure from acquisition-related costs as near-term headwinds, but still pointed to strength in the AI-driven growth pipeline and capital return activity, according to the note.

Oppenheimer said Q1 results beat consensus estimates, driven by strong subscription revenue and continued momentum in large deals and AI adoption, with the company's AI segment expected to reach $1.5 billion in revenue in 2026.

The firm maintained its outperform rating on the stock with a price target of $130.

Shares of ServiceNow were down nearly 16% in Thursday trading.

Price: $86.60, Change: $-16.47, Percent Change: -15.98%

Related Articles

Wire

New Hope Completes AU$300 Million Convertible Notes Offering

New Hope (ASX:NHC) completed a AU$300 million issuance of 2.625% senior unsecured convertible notes due 2032 and the concurrent repurchase of AU$293.3 million of its existing 2029 convertible notes, according to a Thursday filing with the Australian bourse.The new notes are expected to be listed on the Singapore Exchange Securities Trading on or around Thursday, per the filing.The repurchased 2029 notes, which account for around 98% of the outstanding notes, will be cancelled under their terms, the filing said. The company also plans to redeem the remaining AU$6.7 million of notes at par plus accrued interest prior to maturity.

ASX:NHC
Wire

Telix Pharmaceuticals Settles Issue of $600 Million Convertible Notes

Telix Pharmaceuticals (ASX:TLX) said it settled the issue of $600 million in 1.50% convertible notes due 2031, according to a Thursday Australian bourse filing.The convertible notes are expected to be listed on the Official List of the Singapore Exchange Securities Trading on Thursday.In the same filing, the company said that the repurchase of around AU$637 million in principal of the AU$650 million worth of 2.375% convertible bonds due 2029 is "substantially complete."After the repurchase, given that less than 15% in aggregate principal amount of the existing bonds will remain outstanding, Telix said it plans to exercise its right to repurchase and cancel all of the remaining existing bonds at their principal amount.

ASX:TLX
Wire

Century Communities Q1 Adjusted Earnings, Revenue Fall

Century Communities (CCS) reported Q1 adjusted earnings late Wednesday of $0.88 per diluted share, down from $1.39 a year earlier.Three analysts polled by FactSet expected $0.59.Revenue for the three months ended March 31 fell to $789.7 million from $903.2 million a year earlier.Four analysts surveyed by FactSet expected $807.7 million.

$CCS